Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);

Clinical Trial ID NCT04375709

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04375709

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	The hospital anxiety and depression scale.	Acta Psychiatr Scand	1983	121.58
2	Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.	Lancet	2020	18.32
3	Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.	Lancet	2020	10.16
4	Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.	Lancet Respir Med	2020	10.13
5	Functional disability 5 years after acute respiratory distress syndrome.	N Engl J Med	2011	9.96
6	An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.	Am J Respir Crit Care Med	2013	4.49
7	Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: results from the DICES trial.	Thorax	2014	2.09
8	An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease.	Eur Respir J	2014	1.44
9	A systematic review of measurements of physical function in critically ill adults.	Crit Care Resusc	2012	0.85
10	Muscle strength: clinical and prognostic value of hand-grip dynamometry.	Curr Opin Clin Nutr Metab Care	2015	0.83
11	Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD.	Respir Care	2014	0.80
12	Surviving critical illness: what is next? An expert consensus statement on physical rehabilitation after hospital discharge.	Crit Care	2016	0.77